593 related articles for article (PubMed ID: 17261175)
1. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
2. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
Zelvyte I; Wallmark A; Piitulainen E; Westin U; Janciauskiene S
Anticancer Res; 2004; 24(1):241-7. PubMed ID: 15015603
[TBL] [Abstract][Full Text] [Related]
4. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
6. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ragnoli B; Radaeli A
J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
[TBL] [Abstract][Full Text] [Related]
7. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
8. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic flow chart for targeted detection of alpha1-antitrypsin deficiency.
Corda L; Bertella E; Pini L; Pezzini A; Medicina D; Boni E; Guerini M; Trivella S; Grassi V; Tantucci C
Respir Med; 2006 Mar; 100(3):463-70. PubMed ID: 16043335
[TBL] [Abstract][Full Text] [Related]
10. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
11. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
12. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
[TBL] [Abstract][Full Text] [Related]
13. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
Janciauskiene S; Wallmark A; Piitulainen E; Köhnlein T; Welte T; Sveger T
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):716-20. PubMed ID: 21617532
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
[TBL] [Abstract][Full Text] [Related]
15. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
16. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
17. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
18. The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting.
Molina J; Flor X; García R; Timiraos R; Tirado-Conde G; Miravitlles M
Ther Adv Respir Dis; 2011 Aug; 5(4):237-43. PubMed ID: 21652608
[TBL] [Abstract][Full Text] [Related]
19. Alpha-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease.
Kim CH; Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS
Respirology; 2005 Mar; 10(2):223-8. PubMed ID: 15823189
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the detection of the alpha1-antitrypsin "Z" deficiency variant by routine serum protein electrophoresis.
Slev PR; Williams BG; Harville TO; Ashwood ER; Bornhorst JA
Am J Clin Pathol; 2008 Oct; 130(4):568-72. PubMed ID: 18794049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
